Cancer incidence and mortality in the municipality of Pasto, 1998 – 2007
Abstract
Introduction: In Colombia, information on cancer morbidity at the population level is limited. Incidence estimates for most regions are based on mortality data. To improve the validity of these estimates, it is necessary that other population-based cancer registries, as well as Cali, provide cancer risk information.
Objective: To describe the incidence and cancer mortality in the municipality of Pasto within the 1998-2007 period.
Methodology: The study population belongs to rural and urban areas of the municipality of Pasto. Collection, processing, and systematization of the data were performed according to internationally standardized parameters for population-based cancer registries. The cancer incidence and mortality rates were calculated by gender, age, and tumor site.
Results: During the 1998-2007 period 4,986 new cases of cancer were recorded of which 57.7% were in female. 2,503 deaths were presented, 52% in female. Neoplasm-associated infections are the leading cause of cancer morbidity in Pasto: stomach cancer in males and cervical cancer in females.
Discussion: Cancer in general is a major health problem for the population of the municipality of Pasto. The overall behavior of the increasing incidence and cancer mortality in relation to other causes of death show the need to implement and strengthen prevention and promotion programs, focusing especially on tumors that produce greater morbidity and mortality in the population.
Authors
Downloads
Keywords
- Incidence
- mortality
- cancer
- prevention
- Helicobacter pylori
- Human papilloma virus
References
1. Organización Mundial de la Salud. Cáncer Nota descriptiva N° 297. Washington: Organización Mundial de la Salud; 2011.
2. Organización Mundial de la Salud, Unión internacional contra el cáncer. Acción Mundial contra el cáncer. OMS, UICC; 2005. p. 24.
3. Piñeros M, Murillo R. Incidencia de cáncer en Colombia: Importancia de las fuentes de información en la obtención de cifras estimativas. Rev Colomb Cancerol. 2004; 8(1):5 -14.
4. Pardo C, Cendales R. Incidencia estimada y mortalidad por cáncer en Colombia, 2002 -2006. Ministerio de la Protección Social. Instituto Nacional de Cancerología E.S.E. Ministerio de la Protección Social; 2010.
5. International Agency for Research on Cancer; World Health Organization; International Association of Cancer Registries; European network of cancer registries. International rules for multiple primary cancers ICDO. Lyon: IARC; WHO; IACR; ENCR 2004.
6. Estimaciones y proyecciones de población periodo 1985-2020 [database on the Internet]. DANE. [cited 2011]. Available from: http://www.dane.gov.co.
7. Ministerio de la Protección Social. Instituto Nacional de Cancerología, E. S. E. 2011. Guía para el análisis de la situación del cáncer. Colombia. In Serie documentos técnicos INC No. 4.
8. Latin American and Caribbean Demographic Centre. Proyección de población In: Observatorio demográfico, editor. CELADE; 2009.
9. Ortega O, X.A. Villamarín FJ. (2010) Transición demográfica: una dimensión empírica de la modernización en la zona andina de Nariño. Semestre Económico. 2010; 13(27): 117-36.
10. GLOBOCAN 2008, V1,2 Cancer Incidence and Mortality Worldwide. Cancer Base No. 10 [database on the Internet]. 2008 [cited 2011]. Available from: http://globocan.iarc.fr.
11. Gwenn M, Anton K. Social inequalities in cancer incidence and cancer survival: Lessons from Danish studies. Eur J Cancer 2008; 44(14): 1933-7.
12. Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia K, Chen J, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol. 2010; 11(2): 165-73.
13. Cueva P, Yépez C. Epidemiologia del cáncer en quito 2003- 2005. 14 ed. Quito: Sociedad de Lucha contra el Cáncer - SOLCA; 2009.
14. World Health Organization International, Agency for research on cancer. Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens Part B: Biological Agents. Lyon: WHO, IARC; 2009.
15. Wilsnack R, Vogeltanz N, Wilsnack S, Harris T, Ahlström S, Bondy S. Gender differences in alcohol consumption and adverse drinking consequences: cross-cultural patterns. Addiction. 2000; 95(2): 251-65.
16. Curado M, Edwars B, Shin H, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents, Vol. IX. Lyon: International Agency for Research on Cancer, International Association of Cancer Registries; Scientific Publications N°160. 2007.
17. Correa P. A New Paradigm for Human Carcinogenesis. J Clin Gastroenterol 2000; 30(4): 341-2.
18. Camargo M, Yepez M, Ceron C, Guerrero N, Bravo L, Correa P, et al. Age at acquisition of Helicobacter pylori infection: comparison in two areas with contrasting risk of gastric cancer. Helicobacter 2004; 9(3): 262-70.
19. Correa P, Fontham E, Bravo J, Bravo L, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst. 2000; 92(23): 1881-9.
20. Bertuccio B, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, et al. Recent patterns in gastric cancer: A global overview. Int J Cancer. 2009; 125(3): 666-73.
21. Stanley M. Human papillomavirus and cervical carcinogenesis. Best Pract Res Clin Obstet Gynaecol. 2001; 15(5): 663-76.
22. Muñoz N, Bosch F, de Sanjosé S, Herrero R, Castellsagué X, Shah K, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348(6): 518-27.
23. Lewis M. Análisis de la situación del cáncer cervico-uterino en América Latina y el Caribe. Washington, DC: OPS. 2004.
24. Organización Mundial de la Salud, Organización Panamericana de la Salud. Registros de cáncer Información para la acción en América Latina y el Caribe. Lyon OMS-OPS 2012.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use
